Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Florian Thomas, MD PhD
Seton Hall-Hackensack-Meridian School of Medicine, Hackensack, USA
Principal Investigator - Marianne de Visser, MD
Academic Medical Center, Amsterdam, Netherlands
Principal Investigator - Mark Roberts, MD
Selor Royal NHS Foundation Trust, Manchester, UK
Principal Investigator - Shahram Attarian, MD
CHU la Timone, Marseille, France
Principal Investigator - Teresa Sevilla, MD
Hospital Universitario i Politécnico La F, Valencia, Spain
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Departement of Neurology, Uz Leuven
Leuven, Belgium
- University Hospital of Quebec
Québec, Quebec, Canada
- Cntre de Reference Des Maladies Neuromusculaires, Hopital Swynghedauwl, Chu Lille
Lille, France
- Centre de Reference Des Neuropathies Peripheriques Rare, Hopital Dupuytren, Chu Limoges
Limoges, France
- Service de Neurologie Et Du Sommeil, Chu Lyon Sud
Lyon, France
- Centre de Reference Des Maladie Neuromusculaires, Chu la Timone
Marseille, France
- Centre de Reference Des Maladie Neuromusculaires, Hotel Dieu, Chu de Nantes
Nantes, France
- Service de Neurologie, Hopital Kremlin Bicetre
Paris, France
- Departement of Neurology, Academic Medical Center
Amsterdam, Netherlands
- Department of Neurology, Hospital Univesitario de Bellvitge
Barcelona, Spain
- Servicio de Neurologia, Hospital Universitario la Paz
Madrid, Spain
- Centro de Diagnostico Y Tratamiento, Hospital Universitario Virgen del Rocio
Seville, Spain
- Servicio de Neurologia, Hospital Universitario I Politécnic la Fe
Valencia, Spain
- Department of Neurology, Salford Royal Nhs Foundation Trust
Salford, Manchester, United Kingdom
- Department of Neurology, Cedars-Sinai Medical Center
Los Angeles, California, United States
- Department of Neurology, Mcknight Brain Institute
Gainesville, Florida, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Department of Neurology, University of Minnesota
Minneapolis, Minnesota, United States
- Department of Neurology and Psichiatry, Saint Louis University
St Louis, Missouri, United States
- Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center
New York, New York, United States
- Saint Luke'S Rehabilitation Institute
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Mar 2017
- Primary completion
- 31 Dec 2024
- Completion
- 31 Dec 2024
- Last update posted
- 20 Feb 2024
- Registered enrollment
- 187
- Registry id
- NCT03023540
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.